Hadi Casser

Title: Inventor Hadi Casser: Pioneering Innovations in NAD+ Precursors

Introduction

Hadi Casser, an inventive mind based in Northglenn, Colorado, has made significant strides in the field of biochemistry with his patented work on NAD+ increasing precursors. His groundbreaking research focuses on nicotinic acid riboside and its derivatives, aiming to enhance cellular health and survival.

Latest Patents

Hadi Casser holds a patent for the use of nicotinic acid riboside or nicotinamide riboside derivatives as increased precursors of nicotinamide adenine dinucleotide (NAD+). This patent outlines compositions that include nicotinic acid riboside and derivatives such as NAR triacetate and NARH triacetate, among others. The applications of these compounds range from food and beverage formulations to pharmaceutical uses and dietary supplements, promoting the increase of intracellular NAD+ levels for improved cell and tissue health.

Career Highlights

As an inventor at ChromaDex Inc., Hadi Casser has been instrumental in advancing research aimed at understanding and harnessing the benefits of NAD+ and its derivatives. His innovative approach to biochemistry has placed him at the forefront of research that holds potential for diverse applications in health and wellness.

Collaborations

Throughout his career, Hadi has collaborated with notable colleagues, including Ryan Dellinger and Troy Rhonemus. Together, they have contributed to the scientific community's understanding of NAD+ metabolism and its implications for cell health.

Conclusion

Hadi Casser's contributions to the field of biochemistry through his patents signify a pivotal step in enhancing our understanding of cellular vitality and health. His work continues to inspire future innovations in nutritional supplementation and therapeutic formulations aimed at boosting NAD+ levels, showcasing the vital role of inventors in advancing science and health.